Sort
40,608 grants matching “prostate cancer”
GPCR - Linked RhoGEFs in Tumor Growth and Metastasis
$348,611John J G Tesmer · Purdue University · R01 · FY2022 · CA
Targeting aberrant circadian regulator in advanced prostate cancer
$348,607Hongwu Chen · University Of California At Davis · R01 · FY2024 · CA
The Tumor Suppressive Role of CHD5
$348,600Alea Mills · Cold Spring Harbor Laboratory · R01 · FY2010 · CA
The Tumor Suppressive Role of CHD5
$348,600Alea Mills · Cold Spring Harbor Laboratory · R01 · FY2009 · CA
Targeting CD133 for imaging and therapy in prostate cancer
$348,592Aaron Matthew Lebeau · University Of Wisconsin-Madison · R01 · FY2023 · CA
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
$348,592Aaron Matthew Lebeau · University Of Wisconsin-Madison · R01 · FY2023 · CA
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma
$348,592Nicholas K Foreman · University Of Colorado Denver · R01 · FY2023 · CA
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
$348,592Aaron Matthew Lebeau · University Of Wisconsin-Madison · R01 · FY2022 · CA
Epigenetic regulation of LDOC1 drives tumor biology in high risk ependymoma
$348,592Nicholas K Foreman · University Of Colorado Denver · R01 · FY2022 · CA
Cancer and Leukemia Group B
$348,584Eric P Winer · Dana-Farber Cancer Inst · U10 · FY2008 · CA
The Synthesis and Bioassay of Novel Pyrroles
$348,572John T. Gupton · University Of Richmond · R15 · FY2012 · CA
Cancer Epidemiology
$348,543Israel David Goldman · Albert Einstein College Of Medicine, Inc · P30 · FY2017 · CA
Tissue and Specimen Core
$348,530Robert Vessella · Fred Hutchinson Cancer Research Center · P50 · FY2009 · CA
The Tumor Suppressive Role of CHD5
$348,513Alea Mills · Cold Spring Harbor Laboratory · R01 · FY2008 · CA
Quantitative dual-energy CT imaging for radiation therapy treatment planning
$348,490Jeffrey F Williamson · Virginia Commonwealth University · R01 · FY2011 · CA
MR Signal Amplification for Receptor Imaging
$348,465Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · EB
Project 3: Extending Clinical Benefit by Selective Treatment of Resistant Lesions in mCRPC
$348,447Robert Jeraj · University Of Wisconsin-Madison · P50 · FY2024 · CA
Metalloreductases in Medicine
$348,422Mark D Fleming · Boston Children'S Hospital · R01 · FY2010 · DK
Delineating racially distinct metabolic pathways in triple negative breast cancer
$348,403Arun Sreekumar · Baylor College Of Medicine · U01 · FY2014 · CA
Mapping a clinically significant internalizing tumor epitope space.
$348,376Bin Liu · University Of California, San Francisco · R01 · FY2008 · CA
Targeting key orphan nuclear receptor in lethal prostate cancer
$348,363Hongwu Chen · University Of California At Davis · R01 · FY2019 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer
$348,363Yuanpei Li · University Of California At Davis · R01 · FY2019 · CA
Improving chemotherapy of castration-resistant prostate cancer
$348,345Xiaoqi Liu · University Of Kentucky · R01 · FY2020 · CA
Molecular Probes Shed Light on Magnesium Homeostasis
$348,180Daniela Buccella · New York University · R01 · FY2017 · CA
Computer Support for Prostate Cancer Screening in the PLCO Cancer Screening Trial
$348,161William Lake · Information Management Services, Inc. · N02 · FY2009 · CA